Michael S. Budziak
FDA investigator
Appears on 1 document from 2024, mostly at sites in Colorado. Most often cites general requirements (21 CFR 211.160).
- 1
- Documents on file
- 4.0
- Observations per 483
- 2024
- First seen
- 2024
- Most recent
What they cite most
From 4 observations- 21 CFR 211.160General requirements2
- 21 CFR 211.194Laboratory records1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.25Personnel qualifications1
Activity by year
2024: 1
Where
Colorado 1
Often inspects with
Is Michael S. Budziak coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-05-03 | 483 Avista Pharma Solutions, Inc. dba CambrexMay 3, 2024 · Longmont, Colorado | Longmont, Colorado | 4 |
About this profile
What does Michael S. Budziak inspect?
Michael S. Budziak appears on 1 document on file covering 1 site, mostly in Colorado.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.194 and 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Michael S. Budziak is dated May 3, 2024.